MoonLake Immunotherapeutics (MLTX) Net Income (QoQ) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) Net Income (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.35 Bn | 991.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.61% |
| Dec 31, 2025 | 10.86% |
| Sep 30, 2025 | -26.12% |
| Jun 30, 2025 | -38.20% |
| Mar 31, 2025 | 12.58% |
| Dec 31, 2024 | -28.47% |
| Sep 30, 2024 | -45.86% |
| Jun 30, 2024 | -77.17% |
| Mar 31, 2024 | -77.18% |
| Dec 31, 2023 | 32.12% |
| Sep 30, 2023 | 5.94% |
| Jun 30, 2023 | -1.10% |
| Mar 31, 2023 | 25.80% |
| Dec 31, 2022 | -11.71% |
| Sep 30, 2022 | 15.36% |
| Jun 30, 2022 | -9.67% |
| Mar 31, 2022 | 70.40% |
| Dec 31, 2021 | -753.10% |
| Sep 30, 2021 | 80.76% |
| Jun 30, 2021 | -42,743.56% |